Breaking Business News | Breaking business news AM | Breaking Business News PM

Synairgen shares soar after finding drug cuts Covid-19 severity

20 Jul 2020

The inhaled product is a formulation of a naturally occurring protein that Synairgen has previously said may be deficient in those with greater susceptibility to Covid-19

Read the full article here.
This content was originally published by BusinessLIVE. Original publishers retain all rights. It appears here for a limited time before automated archiving. By BusinessLIVE

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.